Anal & Cervical Cancer
Anal & Cervical Cancer
Cervarix Vaccine Protects Women against HPV that Causes Anal Cancer
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 30 August 2011 00:00
- Written by Liz Highleyman
The Cervarix human papillomavirus (HPV) vaccine reduced anal infection with cancer-causing HPV types 16 and 18 in a study of women in Costa Rica, according to a report in the September 2011 issue of The Lancet Oncology.
HPV Vaccine Reduces Cervical Abnormalities
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 05 July 2011 12:32
- Written by Liz Highleyman
Vaccination of young women in Australia against human papillomavirus (HPV) lowered incidence of serious cervical cell abnormalities and early cervical cancer by nearly 40%. 
Anal Pap Screening of HIV+ Men Reveals Half Have Abnormal Cells
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 26 April 2011 04:50
- Written by HIVandHepatitis.com
More than 80% of HIV positive men agreed to undergo Pap screening for anal cancer, demonstrating its feasibility, and 53% showed signs of potentially pre-cancerous abnormal cell growth.
Lopinavir Fights HPV in Cervical Cancer Cells
- Details
- Category: Human Papillomavirus (HPV)
- Published on Thursday, 05 May 2011 18:26
- Written by University of Manchester
The HIV protease inhibitor lopinavir (the main drug in Kaletra) blocked viral proteasome activitation and selectively killed pre-cancerous cervical cells infected with human papillomavirus (HPV).
As reported in the May 3, 2011, advance online edition of Antiviral Therapy, Gavin Batman and Ian Hampson from the University of Manchester in the U.K. and colleagues tested lopinavir in HPV-infected SiHa cervical carcinoma cells in a laboratory study.
Gardasil HPV Vaccine Approved for Anal Cancer
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 07 January 2011 12:55
- Written by FDA
On December 22, 2010, the U.S. Food and Drug Administration (FDA) approved the use of Merck's quadrivalent human papillomavirus (HPV) vaccine, Gardasil, for prevention of anal cancer in men and women age 9-26 years. The vaccine -- which targets high-risk HPV types 6, 11, 16, and 18 -- was previously approved for prevention of cervical cancer in young women.
More Articles...
- Anal Pap Smears to Detect Pre-cancerous Cell Changes Are as Effective as Cervical Screening, especially at Low CD4 Counts
- Anal Cancer Treatment Is Equally Effective for HIV Positive and HIV Negative People
- Many HIV Positive Women Do Not Receive Recommended Regular Pap Smears for Cervical Cancer
- Studies Shed Further Light on HPV Infection and Anal Cancer in HIV+ People
Web Design and Development by